ZNTL — ZENTALIS PHARMACEUTICALS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 120 家机构在其最新 13F 申报中持有 ZNTL(ZENTALIS PHARMACEUTICALS INC),合计申报市值 $197.46M,对应 40.94M 股。按股数计算较上季度增持 0.6%(+232.49K 股),申报市值环比上升 108.2%。持仓集中度较高:前五大持有人占申报市值的 37.3%,前十大的集中度为 53.7%。
与上一季度相比,38 家新建仓位、28 家加仓、32 家减仓、23 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ZENTALIS PHARMACEUTICALS INC(ZNTL)的主要机构持有人包括 Viking Global Investors、Avidity Partners Management LP、Sofinnova Investments, Inc.,按 13F 申报市值在本页 310 家持有人中排名居前。
ZNTL 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 81 | 26.60M | $73.50M | +19.8% |
| Q2 2026 | 120 | 40.94M | $197.46M | +0.6% |
| Q1 2026 | 105 | 38.07M | $88.83M | -5.1% |
| Q4 2025 | 89 | 40.23M | $54.44M | +19.9% |
| Q3 2025 | 100 | 49.12M | $74.18M | -10.9% |
| Q2 2025 | 116 | 55.94M | $64.86M | -6.3% |
| Q1 2025 | 130 | 59.91M | $95.15M | +4.7% |
| Q4 2024 | 139 | 62.16M | $185.39M | -15.6% |
表内 8 个季度中,机构持股合计减少 57%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+19.9%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.91M | $10.84M | 0.00% | 增持 | |
| 3.52M | $9.76M | 0.00% | 增持 | |
| 2.01M | $5.56M | 0.89% | 新进 | |
| 1.50M | $4.15M | 0.01% | 减持 | |
| 1.32M | $3.67M | 0.54% | 持有 | |
| 1.29M | $3.56M | 0.00% | 持有 | |
| 1.27M | $3.52M | 0.00% | 增持 | |
| 1.14M | $3.14M | 0.01% | 增持 | |
| 1.11M | $3.08M | 0.00% | 增持 | |
| 957.42K | $2.65M | 0.00% | 持有 | |
| 951.15K | $2.58M | 0.00% | 增持 | |
| 953.83K | $2.58M | 1.57% | 持有 | |
| 706.23K | $1.96M | 0.00% | 增持 | |
| 677.72K | $1.88M | 0.00% | 增持 | |
| 664.86K | $1.84M | 0.00% | 减持 | |
| 426.89K | $1.18M | 0.00% | 减持 | |
| 379.88K | $1.05M | 0.00% | 增持 | |
| 306.66K | $849.45K | 0.00% | 增持 | |
| 255.02K | $706.42K | 0.00% | 增持 | |
| 254.76K | $705.68K | 0.54% | 增持 | |
| 238.38K | $660.32K | 0.00% | 增持 | |
| 205.38K | $568.89K | 0.00% | 减持 | |
| 203.92K | $564.86K | 0.00% | 减持 | |
| 172.42K | $477.59K | 0.00% | 新进 | |
| 157.14K | $435.29K | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.95M | $9.24M | 2.56% | 持有 | |
| 2.96M | $6.92M | 0.01% | 增持 | |
| 2.31M | $5.41M | 0.00% | 新进 | |
| 1.94M | $4.54M | 0.01% | 减持 | |
| 1.48M | $3.47M | 0.00% | 减持 | |
| 1.48M | $3.47M | 0.01% | 减持 | |
| 1.41M | $3.31M | 0.45% | 增持 | |
| 1.32M | $3.10M | 0.47% | 持有 | |
| 1.29M | $3.02M | 0.00% | 增持 | |
| 1.29M | $3.02M | 0.00% | 增持 | |
| 1.27M | $2.97M | 0.00% | 增持 | |
| 1.23M | $2.88M | 2.93% | 减持 | |
| 1.13M | $2.65M | 0.00% | 减持 | |
| 957.42K | $2.24M | 0.00% | 持有 | |
| 953.83K | $2.00M | 0.84% | 持有 | |
| 792.00K | $1.85M | 0.00% | 增持 | |
| 637.12K | $1.49M | 0.00% | 增持 | |
| 621.04K | $1.45M | 0.00% | 增持 | |
| 620.41K | $1.45M | 0.09% | 减持 | |
| 610.07K | $1.43M | 0.32% | 持有 | |
| 591.22K | $1.38M | 0.00% | 增持 | |
| 490.34K | $1.15M | 0.00% | 增持 | |
| 471.44K | $1.10M | 0.00% | 增持 | |
| 462.68K | $1.08M | 0.00% | 增持 | |
| 400.00K | $936.00K | 0.40% | 新进 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.95M | $5.33M | 1.68% | 增持 | |
| 2.88M | $3.89M | 0.01% | 增持 | |
| 2.86M | $3.86M | 0.00% | 减持 | |
| 1.96M | $2.65M | 0.00% | 增持 | |
| 1.66M | $2.24M | 0.00% | 增持 | |
| 1.66M | $2.24M | 0.00% | 增持 | |
| 1.48M | $2.00M | 0.00% | 增持 | |
| 1.47M | $1.99M | 0.00% | 增持 | |
| 1.40M | $1.89M | 0.25% | 增持 | |
| 1.37M | $1.85M | 0.00% | 减持 | |
| 1.32M | $1.79M | 0.24% | 持有 | |
| 1.32M | $1.78M | 2.04% | 新进 | |
| 1.25M | $1.69M | 0.00% | 持有 | |
| 1.17M | $1.58M | 0.14% | 增持 | |
| 957.42K | $1.29M | 0.00% | 减持 | |
| 953.83K | $1.29M | 0.55% | 持有 | |
| 803.65K | $1.08M | 0.00% | 减持 | |
| 787.05K | $1.06M | 0.00% | 增持 | |
| 674.60K | $910.71K | 0.00% | 增持 | |
| 673.13K | $908.72K | 0.00% | 减持 | |
| 673.13K | $908.72K | 0.00% | 减持 | |
| 610.07K | $823.60K | 0.18% | 增持 | |
| 589.11K | $795.72K | 0.00% | 持有 | |
| 576.71K | $778.55K | 0.02% | 增持 | |
| 568.44K | $767.40K | 0.00% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 13.96M | $21.08M | 19.75% | 持有 | |
| 2.90M | $4.39M | 0.00% | 增持 | |
| 2.33M | $3.51M | 0.01% | 增持 | |
| 1.55M | $2.34M | 0.09% | 持有 | |
| 1.55M | $2.34M | 0.00% | 增持 | |
| 1.46M | $2.21M | 0.00% | 增持 | |
| 1.41M | $2.13M | 0.00% | 增持 | |
| 1.41M | $2.13M | 0.00% | 增持 | |
| 1.41M | $2.13M | 0.00% | 增持 | |
| 1.36M | $2.06M | 0.00% | 增持 | |
| 1.32M | $2.00M | 0.35% | 持有 | |
| 1.25M | $1.89M | 0.00% | 减持 | |
| 1.19M | $1.79M | 0.01% | 增持 | |
| 1.08M | $1.63M | 0.14% | 减持 | |
| 962.62K | $1.45M | 0.00% | 减持 | |
| 953.83K | $1.44M | 0.33% | 持有 | |
| 902.52K | $1.36M | 0.00% | 减持 | |
| 902.52K | $1.36M | 0.00% | 减持 | |
| 723.08K | $1.09M | 0.00% | 增持 | |
| 700.58K | $1.06M | 0.00% | 减持 | |
| 645.62K | $974.89K | 0.00% | 减持 | |
| 589.22K | $890.23K | 0.00% | 减持 | |
| 565.37K | $853.88K | 0.76% | 增持 | |
| 548.63K | $828.43K | 0.04% | 增持 | |
| 532.68K | $804.34K | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 13.96M | $16.19M | 7.27% | 持有 | |
| 3.48M | $4.03M | 0.01% | 增持 | |
| 3.48M | $4.03M | 0.00% | 增持 | |
| 2.88M | $3.35M | 0.00% | 减持 | |
| 1.92M | $2.23M | 0.46% | 减持 | |
| 1.74M | $2.02M | 0.00% | 减持 | |
| 1.60M | $1.86M | 0.47% | 减持 | |
| 1.55M | $1.80M | 0.09% | 增持 | |
| 1.53M | $1.77M | 0.00% | 增持 | |
| 1.32M | $1.54M | 0.39% | 减持 | |
| 1.28M | $1.48M | 0.00% | 增持 | |
| 1.20M | $1.39M | 0.00% | 增持 | |
| 1.20M | $1.39M | 0.00% | 增持 | |
| 1.13M | $1.31M | 0.09% | 增持 | |
| 1.10M | $1.27M | 0.00% | 持有 | |
| 1.09M | $1.27M | 0.00% | 增持 | |
| 1.03M | $1.19M | 0.00% | 减持 | |
| 970.86K | $1.13M | 0.00% | 新进 | |
| 953.83K | $1.11M | 0.19% | 持有 | |
| 861.77K | $999.65K | 0.00% | 增持 | |
| 857.58K | $994.79K | 0.00% | 增持 | |
| 713.32K | $827.45K | 0.00% | 减持 | |
| 664.06K | $770.31K | 0.00% | 增持 | |
| 618.17K | $717.43K | 0.00% | 减持 | |
| 559.21K | $648.73K | 0.65% | 持有 |
新建仓(Q2 2026)
- ORBIMED ADVISORS LLC 1.39M 股 · $6.74M
- GEODE CAPITAL MANAGEMENT, LLC 1.28M 股 · $6.23M
- Soleus Capital Management, L.P. 950.00K 股 · $4.61M
- Sixth Street Partners Management Company, L.P. 171.91K 股 · $833.77K
- Informed Momentum Co LLC 126.86K 股 · $615.29K
- BNY Mellon 122.07K 股 · $592.03K
- Susquehanna Portfolio Strategies, LLC 112.12K 股 · $543.79K
- ExodusPoint Capital Management, LP 74.97K 股 · $363.58K
- Nuveen, LLC 66.67K 股 · $323.37K
- RHUMBLINE ADVISERS 55.76K 股 · $270.43K
- Deutsche Bank AG 48.81K 股 · $236.71K
- PRICE T ROWE ASSOCIATES INC /MD/ 41.05K 股 · $200.00K
完全清仓(较上季)
- Almitas Capital LLC 卖出 610.07K 股 · $1.43M
- Anfield Capital Management, LLC 卖出 274.52K 股 · $642.37K
- Woodline Partners LP 卖出 266.03K 股 · $622.51K
- STATE STREET CORP 卖出 249.69K 股 · $584.27K
- PANAGORA ASSET MANAGEMENT INC 卖出 139.69K 股 · $326.88K
- Hudson Bay Capital Management LP 卖出 117.13K 股 · $274.08K
- Point72 Asset Management 卖出 94.85K 股 · $221.96K
- 49 WEALTH MANAGEMENT, LLC 卖出 66.40K 股 · $155.38K
- HRT FINANCIAL LP 卖出 52.19K 股 · $122.00K
- OMERS ADMINISTRATION Corp 卖出 47.70K 股 · $111.62K
- Brevan Howard Capital Management LP 卖出 47.06K 股 · $110.13K
- TUDOR INVESTMENT CORP ET AL 卖出 34.85K 股 · $81.55K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 3.91M | 3.75M | 1.27M | 1.25M | 1.25M | 1.74M | 4.23M | 4.24M | 4.76M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.52M | 2.84M | 2.31M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Patient Square Capital LP | 2.01M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 1.50M | 1.61M | 1.94M | 2.88M | 2.33M | 1.53M | 826.04K | 539.35K | 556.94K | 661.68K | 261.94K | 309.28K | 285.44K | 210.44K | 32.74K | — | — | — | 109.34K | — |
| Decheng Capital LLC | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 2.02M | 2.34M | 3.11M | 3.07M | 2.10M | 2.10M | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.29M | 1.28M | 621.04K | 589.11K | 589.22K | 618.17K | 1.36M | 1.31M | 1.29M | 1.33M | 1.30M | 1.25M | 1.19M | 1.07M | 895.92K | 857.22K | 836.21K | 781.44K | 666.06K | 661.21K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.27M | 808.55K | 360.60K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 1.14M | 574.81K | 637.12K | 17.47K | 56.64K | 32.11K | — | — | — | — | — | 50.20K | 141.39K | — | — | — | — | — | — | — |
| STATE STREET CORP | 1.11M | — | 249.69K | 271.79K | 271.79K | 271.79K | 1.32M | 1.29M | 1.25M | 3.05M | 3.79M | 4.42M | 2.70M | — | — | — | — | — | — | — |
| PRIMECAP MANAGEMENT CO/CA/ | 957.42K | 957.42K | 957.42K | 957.42K | 962.62K | 1.03M | 1.26M | 1.52M | 1.50M | 1.23M | 1.16M | 1.02M | 1.03M | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 951.15K | 22.44K | 113.13K | 185.01K | 723.08K | 550.45K | 746.48K | 859.71K | 489.20K | 495.81K | 58.62K | 93.45K | 101.93K | 110.69K | 3.11K | 46.84K | 5.60K | 56.70K | 105.58K | 27.48K |
| PFIZER INC | 953.83K | 953.83K | 953.83K | 953.83K | 953.83K | 953.83K | 953.83K | 953.83K | — | — | — | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 706.23K | 542.85K | 272.03K | 96.26K | 185.03K | 335.97K | 447.40K | 505.01K | 505.64K | 626.66K | 723.66K | 724.03K | 484.32K | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 677.72K | 310.26K | 283.92K | 243.31K | 203.31K | 184.68K | 182.19K | 182.31K | 5.08M | 8.68M | 10.64M | 10.34M | 9.49M | 10.58M | 8.91M | 7.91M | 7.57M | 7.78M | 6.74M | 6.80M |
| Connor, Clark & Lunn Investment Management Ltd. | 664.86K | 758.03K | 792.00K | 787.05K | 380.82K | 314.85K | 361.24K | 345.04K | 229.14K | 101.27K | 19.47K | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 426.89K | 591.47K | 392.64K | 247.79K | — | — | — | 89.01K | 89.01K | 89.01K | 89.01K | 89.01K | 270.84K | 516.04K | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 379.88K | 336.94K | 304.47K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Creative Planning | 306.66K | 285.00K | 285.00K | 260.00K | 260.00K | 30.34K | 236.52K | 40.10K | 11.30K | 13.40K | 11.59K | 11.00K | — | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 255.02K | 13.49K | 30.69K | 107.73K | 21.32K | 46.46K | 49.10K | 50.76K | 115.11K | 148.75K | 23.11K | — | 45.47K | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 254.76K | 161.58K | 269.10K | 463.70K | 453.80K | 109.01K | 60.00K | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ZNTL?
As of 2026-Q2, 120 institutional funds reported holding ZNTL (ZENTALIS PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $197.46M.
How many shares of ZNTL do institutions own?
13F filers reported 40.94M shares of ZNTL, worth $197.46M in aggregate at the end of 2026-Q2.
Is institutional ownership of ZNTL rising or falling?
Share counts moved +0.6% versus the prior quarter — accumulation.
Who are the top institutional holders of ZNTL?
The largest 13F holders are Viking Global Investors, Avidity Partners Management LP, Sofinnova Investments, Inc., Matrix Capital Management Company, LP, 5AM Venture Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ZENTALIS PHARMACEUTICALS INC?
The major shareholders of ZENTALIS PHARMACEUTICALS INC (ZNTL) by reported 13F value are Viking Global Investors, Avidity Partners Management LP, Sofinnova Investments, Inc., Matrix Capital Management Company, LP, 5AM Venture Management, LLC, among 310 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.